Tower Research Capital (TRC)’s ENvue Medical Inc FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.71K Buy
2,819
+1,014
+56% +$2.2K ﹤0.01% 4042
2025
Q4
$4.17K Buy
1,805
+1,178
+188% +$5.55K ﹤0.01% 4250
2025
Q3
$3.54K Buy
627
+401
+177% +$3.02K ﹤0.01% 4486
2025
Q2
$2.1K Buy
226
+124
+122% +$3.7K ﹤0.01% 4701
2025
Q1
$3.46K Buy
102
+47
+85% +$2.16K ﹤0.01% 4406
2024
Q4
$3.57K Hold
55
﹤0.01% 4636
2024
Q3
$3.71K Hold
55
﹤0.01% 4789
2024
Q2
$4.25K Hold
55
﹤0.01% 4798
2024
Q1
$5.45K Buy
55
+7
+15% +$758 ﹤0.01% 4542
2023
Q4
$6.05K Buy
48
+20
+71% +$2.45K ﹤0.01% 4783
2023
Q3
$6.16K Buy
28
+16
+133% +$4.76K ﹤0.01% 4637
2023
Q2
$4.54K Buy
12
+5
+71% +$1.94K ﹤0.01% 4934
2023
Q1
$3K Buy
+7
New +$3.77K ﹤0.01% 5212
2022
Q2
Sell
-3
Closed -$8K 6366
2022
Q1
$8K Buy
+3
New +$5.66K ﹤0.01% 4597
2021
Q4
Sell
-1
Closed -$3K 6408
2021
Q3
$3K Buy
+1
New +$4.43K ﹤0.01% 5119
2021
Q2
Hold
0
5710
2021
Q1
Hold
0
5601
2020
Q3
Hold
0
5004
2020
Q2
Hold
0
4895
2020
Q1
Hold
0
-$1K 3590
2019
Q4
Hold
0
3288
2019
Q3
Hold
0
4372
2019
Q2
Hold
0
4069
2019
Q1
Hold
0
-$1K 4113
2018
Q4
Hold
0
3628
2018
Q3
Hold
0
4083
2018
Q2
Hold
0
-$2K 3913
2018
Q1
Sell
-1
Closed -$10.1K 2952
2017
Q4
$12K Buy
+1
New +$10K ﹤0.01% 2441

Other funds holding FEED

Tower Research Capital (TRC)'s FEED Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its ENvue Medical Inc (FEED) stake by 56% in Q1 2026, buying an estimated $2.2K and bringing the position to 2,819 shares worth $6.71K. The position accounts for ﹤0.01% of the portfolio, ranked #4042.

Tower Research Capital (TRC) first reported a position in FEED in Q4 2017 and has held it in 16 quarters since. The position peaked at $12K in Q4 2017. 13 funds tracked by Wall St. Rank hold FEED as of Q1 2026.

  • Tower Research Capital (TRC) held 2,819 shares of ENvue Medical Inc worth $6.71K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,014 ENvue Medical Inc shares in Q1 2026, an estimated $2.2K.
  • ENvue Medical Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4042 holding.
  • Tower Research Capital (TRC) first reported a position in ENvue Medical Inc in Q4 2017 and has held it in 16 quarters since.
  • Tower Research Capital (TRC)'s ENvue Medical Inc position peaked at $12K in Q4 2017.
  • 13 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.